Conference Coverage

Upfront NGS testing of metastatic NSCLC saves money, time

Publish date: May 17, 2018

 

REPORTING FROM THE ASCO ANNUAL MEETING

SOURCE: Pennell et al., ASCO Annual Meeting Abstract 9031.

Pages

Recommended Reading

The T-cell repertoire in NSCLC: Therapeutic implications
Journal of Clinical Outcomes Management
Imfinzi approved for stage III unresectable NSCLC
Journal of Clinical Outcomes Management
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States
Journal of Clinical Outcomes Management
Qualitative assessment of organizational barriers to optimal lung cancer care in a community hospital setting in the United States
Journal of Clinical Outcomes Management